ALA 3.95% 19.8¢ arovella therapeutics limited

March, page-4

  1. 4,749 Posts.
    lightbulb Created with Sketch. 246
    Hi matrix

    You will no doubt not forgotten that the WHO MPAC are meeting in Geneva 5-7th March. I am really hopeful that from this meeting will be some clear direction for the use of ArTiMist as a Pediatric pre-referral treatment. I am also hopeful there may be some further mention of a sponsored trial programme for extending the use of ArTiMist to adults. It usually takes a little while for the outcomes from these meetings to be published.

    kippax
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
19.8¢
Change
0.008(3.95%)
Mkt cap ! $208.6M
Open High Low Value Volume
19.5¢ 20.0¢ 19.5¢ $221.8K 1.136M

Buyers (Bids)

No. Vol. Price($)
1 29412 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 271572 4
View Market Depth
Last trade - 13.16pm 12/11/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.